SCHEMBL31197390

SCHEMBL31197390

CCCCCCOCCc1cccc2c1C(=O)NC2=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1H2 P55055 1/20 0.37
▸ NR1H3 Q13133 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ ELANE P08246 6/20 0.36
▸ CTSG P08311 2/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ RECQL P46063 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ GPR84 Q9NQS5 1/20 0.35
▸ CNR2 P34972 1/20 0.34
▸ PTPN1 P18031 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10726425 0.95 NR1H2 (0.40) NR1H2NR1H3KDM4EALDH1A1GAA
SCHEMBL29699243 0.86 NR1H2 (0.49) NR1H2NR1H3KDM4EALDH1A1GAA
SCHEMBL9402093 0.86 NR1H2 (0.49) NR1H2NR1H3KDM4EALDH1A1GAA
SCHEMBL29699236 0.86 NR1H2 (0.49) NR1H2NR1H3KDM4EALDH1A1GAA
SCHEMBL10725524 0.86 NR1H2 (0.49) NR1H2NR1H3KDM4EALDH1A1GAA
SCHEMBL29699171 0.86 NR1H2 (0.49) NR1H2NR1H3KDM4EALDH1A1GAA
SCHEMBL10725242 0.86 NR1H2 (0.49) NR1H2NR1H3KDM4EALDH1A1GAA
SCHEMBL8684492 0.86 NR1H2 (0.49) NR1H2NR1H3KDM4EALDH1A1GAA
SCHEMBL10730459 0.86 NR1H2 (0.49) NR1H2NR1H3KDM4EALDH1A1GAA
SCHEMBL29699310 0.86 NR1H2 (0.49) NR1H2NR1H3KDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12139483-B2 Imidazoquinolyl compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity PHARMA CINQ, LLC (US) 2024-11-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12139483-B2 Imidazoquinolyl compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity NOD1, NLRP3, AADAC NR1H2 3694/4885NR1H3 3989/4885KDM4E 1620/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback